Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Inovio Pharma (INO)

Inovio Pharma (INO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,110,582
  • Shares Outstanding, K 158,096
  • Annual Sales, $ 4,110 K
  • Annual Income, $ -119,360 K
  • 60-Month Beta 1.34
  • Price/Sales 507.12
  • Price/Cash Flow N/A
  • Price/Book 10.24

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.18
  • Number of Estimates 4
  • High Estimate -0.16
  • Low Estimate -0.18
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.53 +40.08%
on 05/01/20
16.92 -21.10%
on 05/20/20
-0.40 (-2.91%)
since 04/28/20
3-Month
3.83 +248.56%
on 03/02/20
19.36 -31.04%
on 03/09/20
+9.07 (+211.92%)
since 02/28/20
52-Week
1.91 +597.13%
on 10/02/19
19.36 -31.04%
on 03/09/20
+10.21 (+325.16%)
since 05/28/19

Most Recent Stories

More News
5 High Beta ETFs That Are in High Momentum

Markets may rally ahead on hopes of coronavirus vaccines and recovering consumer sentiments. These high-beta ETFs that are in high momentum should gain ahead.

MRNA : 55.54 (+6.44%)
NVAX : 44.84 (-1.37%)
INO : 13.35 (+1.21%)
FYT : 29.87 (-3.95%)
XWEB : 93.09 (+0.24%)
PSCD : 52.92 (-3.21%)
KBWD : 13.20 (-2.87%)
SPTM : 37.12 (-0.27%)
Biotech Stock Roundup: REGN's Stake Buyback, INO, NVAX's Coronavirus Updates & More

The biotech sector remains in focus with updates on coronavirus treatments and other pipeline updates.

REGN : 578.21 (+6.29%)
SNY : 48.68 (+2.51%)
NVAX : 44.84 (-1.37%)
INO : 13.35 (+1.21%)
ICPT : 72.74 (-2.27%)
ARGX : 211.68 (-0.91%)
Thinking about trading stocks or options in Inovio Pharmaceuticals, Canopy Growth Corp, United Airlines, Rockwell Automation, or Wells Fargo?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for INO, CGC, UAL, ROK, and WFC.

CGC : 21.72 (+9.15%)
INO : 13.35 (+1.21%)
ROK : 216.40 (-1.30%)
WFC : 27.22 (-2.61%)
Here's How Americans Are Regaining Confidence: 5 Picks

U.S. consumer confidence gained in May and beat the expectations of economists polled by Dow Jones.

MRNA : 55.54 (+6.44%)
NVAX : 44.84 (-1.37%)
BGS : 23.39 (-2.26%)
MED : 98.10 (-1.38%)
INO : 13.35 (+1.21%)
CLXT : 4.46 (-4.29%)
PRPL : 14.11 (-1.74%)
ONEW : 14.99 (-3.91%)
Shareholder Alert: Robbins LLP Is Investigating the Officers and Directors of Inovio Pharmaceuticals, Inc. (INO)

Shareholder rights law firm Robbins LLP announces that it is investigating the officers and directors of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) for breaches of fiduciary duties and violations of the...

INO : 13.35 (+1.21%)
Tap the Solid Momentum in These 5 Solid High-Beta Stocks

Markets may rally ahead on hopes of coronavirus vaccines and recovering consumer sentiments. These high-beta stocks that are in high momentum should gain ahead.

EQT : 13.37 (-5.65%)
ADTN : 11.14 (-2.11%)
MRNA : 55.54 (+6.44%)
ETSY : 77.81 (+2.06%)
MEIP : 3.30 (-1.79%)
INO : 13.35 (+1.21%)
INOVIO to Host Webinar "DNA Medicines: From COVID-19 to Cancer"

, /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to protect and treat people from infectious diseases, cancer, and...

INO : 13.35 (+1.21%)
Stocks & ETFs Beneficiaries of Coronavirus Vaccine Ramp-Up

Efforts in formulating a coronavirus vaccine are heating up. These stocks and ETFs look to be the largest beneficiaries.

AZN : 53.50 (+1.96%)
MRNA : 55.54 (+6.44%)
GSK : 41.54 (+1.47%)
NVAX : 44.84 (-1.37%)
CNCR : 25.78 (-1.42%)
INO : 13.35 (+1.21%)
PTH : 112.46 (+0.47%)
BBC : 40.91 (-2.13%)
BTEC : 42.06 (-0.93%)
ARKG : 45.29 (-1.86%)
IDN : 5.95 (-5.56%)
VXRT : 2.65 (+0.76%)
GNOM : 16.37 (-1.40%)
INO July 2nd Options Begin Trading

Investors in Inovio Pharmaceuticals Inc. saw new options begin trading today, for the July 2nd expiration.

INO : 13.35 (+1.21%)
Inovio, Spotify rise; Urban Outfitters, Eaton Vance fall

NEW YORK (AP) — Stocks that moved heavily or traded substantially on Wednesday:

MCK : 156.86 (+0.98%)
ADI : 110.96 (-3.24%)
EV : 37.91 (-3.14%)
URBN : 17.72 (-6.83%)
INO : 13.35 (+1.21%)
HOV : 16.01 (-6.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade INO with:

Business Summary

Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled...

See More

Key Turning Points

2nd Resistance Point 14.55
1st Resistance Point 13.95
Last Price 13.35
1st Support Level 12.75
2nd Support Level 12.15

See More

52-Week High 19.36
Last Price 13.35
Fibonacci 61.8% 12.70
Fibonacci 50% 10.64
Fibonacci 38.2% 8.58
52-Week Low 1.91

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar